Related Experiment Videos
Heparin bleeding due to qualitative platelet dysfunction.
Angiology
|September 1, 1979
Summary
Heparin, an anticoagulant, can cause bleeding by affecting platelet function. This study observed prolonged bleeding times in a patient receiving heparin for thromboembolic disease, suggesting a link to platelet dysfunction.
Area of Science:
- Hematology
- Pharmacology
Background:
- Thromboembolic disease necessitates anticoagulant therapy, commonly with heparin.
- Heparin is known to affect coagulation and platelet function.
Observation:
- A 26-year-old woman experienced arterial bleeding during heparin therapy for thromboembolic disease.
- Bleeding recurred upon re-administration of heparin two years later.
Findings:
- Bleeding time was prolonged in the patient when she was ill and receiving heparin.
- The patient's bleeding episodes correlated with heparin administration, suggesting a drug-induced effect.
Implications:
- Heparin may induce bleeding through qualitative platelet dysfunction.
- Further investigation into heparin's effects on platelet function is warranted.
- This finding may inform clinical management of patients on heparin therapy.